Therapeutic Targets Database
BIDD Pharmainformatics Databases


TTD Target ID: TTDC00025

Target Information
NamePhospholipase A2, membrane associated    
Type of targetClinical trial target    
SynonymsGIIC sPLA2    
Group IIA phospholipase A2    
Non-pancreatic secretory phospholipase A2    
Phosphatidylcholine 2-acylhydrolase    
[ICD9: 414.0, 440   ICD10: I70]
Coronary Artery Disease
[ICD9: 410-414, 429.2   ICD10: I20-I25]
Drug(s)VarespladibPhase IICoronary Artery Disease, Atherosclerosis[1][2]
EC NumberEC
PathwayArachidonic acid metabolism
Ether lipid metabolism
Fc epsilon RI signaling pathway
Glycerophospholipid metabolism
GnRH signaling pathway
Linoleic acid metabolism
Long-term depression
MAPK signaling pathway
Metabolic pathways
VEGF signaling pathway
Vascular smooth muscle contraction
alpha-Linolenic acid metabolism
UniProt IDP14555
PDB Structure1AYP; 1BBC; 1DB4; 1DB5; 1DCY; 1J1A; 1KQU; 1KVO; 1N28; 1N29; 1POD; 1POE; 2GNY; 3U8B; 3U8D; 3U8H; 3U8I.    
Target ValidationClick to Find Target Validation Information.    
2- (4-phenoxyphenoxy)ethanamine[4]
Isopropyl Alcohol[9]
Lauric Acid[5]
N-Tridecanoic Acid[9]
Varespladib sodium[12]
cacospongionolide E[7]
Cross References 3D Structure
Related Literature
On-Line Medical Dictionary
Ref 1Update on patented cholesterol absorption inhibitors. Expert Opin Ther Pat. 2009 Aug;19(8):1083-107. To Reference
Ref 2Effects of 1-H-indole-3-glyoxamide (A-002) on concentration of secretory phospholipase A2 (PLASMA study): a phase II double-blind, randomised, placebo-controlled trial. Lancet. 2009 Feb 21;373(9664):649-58. To Reference
Ref 3Satta R, Dimitrijevic N, Manev H: Drosophila metabolize 1,4-butanediol into gamma-hydroxybutyric acid in vivo. Eur J Pharmacol. 2003 Jul 25;473(2-3):149-52. To Reference
Ref 4J Med Chem. 2008 Dec 25;51(24):7882-8.Discovery of multitarget inhibitors by combining molecular docking with common pharmacophore matching. To Reference
Ref 5Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. To Reference
Ref 6J Nat Prod. 2001 May;64(5):612-5.New sesquiterpene derivatives from the sponge Dysidea species with a selective inhibitor profile against human phospholipase A2 and other leukocyte functions. To Reference
Ref 7J Nat Prod. 1998 Jul;61(7):931-5.A new cacospongionolide inhibitor of human secretory phospholipase A2 from the Tyrrhenian sponge Fasciospongia cavernosa and absolute configuration of cacospongionolides. To Reference
Ref 8Bioorg Med Chem Lett. 2008 Oct 15;18(20):5415-9. Epub 2008 Sep 12.Simplified YM-26734 inhibitors of secreted phospholipase A2 group IIA. To Reference
Ref 9Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. To Reference
Ref 10J. Nat. Prod. 55(12):1701-1717 (1992) To Reference
Ref 11Bioorg Med Chem Lett. 2006 May 1;16(9):2373-5. Epub 2006 Feb 28.Synthesis of phospholipase A2 inhibitory biflavonoids. To Reference
Ref 12J Med Chem. 2008 Aug 14;51(15):4708-14. Epub 2008 Jul 8.Highly specific and broadly potent inhibitors of mammalian secreted phospholipases A2. To Reference


Welcome to sign our Guestbook.

If you find any error in data or bug in web service, please kindly report it to Dr. Zhu.

Dr. Chen Yuzong
Deputy Director of Center for Computational Science and Engineering
Professor in Department of Pharmacy
National University of Singapore, Singapore

All rights reserved.

Computer-aided Drug Design
about BIDD |  databases |  software |  teaching |  research |  links


Department of Computational Science | National University of Singapore | Blk S17, 3 Science Drive 2, Singapore 117543